Comment
doi: 10.1200/JCO.2000.18.23.4001.
Standard chemotherapy for gastric carcinoma: is it a myth?
- PMID: 11099333
- DOI: 10.1200/JCO.2000.18.23.4001
Item in Clipboard
Comment
Standard chemotherapy for gastric carcinoma: is it a myth?
J Clin Oncol.
.
No abstract available
Comment in
-
Standard chemotherapy for gastric carcinoma: is it a myth?J Clin Oncol. 2001 May 15;19(10):2765-7. doi: 10.1200/JCO.2001.19.10.2765. J Clin Oncol. 2001. PMID: 11352971 No abstract available.
Comment on
-
Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group.J Clin Oncol. 1991 May;9(5):827-31. doi: 10.1200/JCO.1991.9.5.827. J Clin Oncol. 1991. PMID: 2016625 Clinical Trial.
-
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.J Clin Oncol. 1997 Jan;15(1):261-7. doi: 10.1200/JCO.1997.15.1.261. J Clin Oncol. 1997. PMID: 8996151 Clinical Trial.
-
Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group.J Clin Oncol. 2000 Jul;18(14):2648-57. doi: 10.1200/JCO.2000.18.14.2648. J Clin Oncol. 2000. PMID: 10894863 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
